Healthleap, founded in 2022, has raised $38 million in combined seed and Series A rounds to advance its AI-driven platform designed to spot hospitalized patients at risk of overlooked illnesses such as malnutrition and delirium.
- $38M raised including $8M seed and $30M Series A
- AI integrates language models with EHR data to flag at-risk patients
- Over 50 hospitals use the platform, noting 5x+ ROI
What happened
Healthleap announced it has secured $38 million in new funding, combining an $8 million seed round co-led by Sequoia Capital and First Round Capital with a $30 million Series A led by Hummingbird Ventures. Founded in South Africa by Jemima and Josiah Meyer in 2022, Healthleap initially focused on clinical nutrition tools before pivoting to a broader AI platform that analyzes hospital patient records to flag possible undiagnosed conditions.
The startup uses natural language processing to extract clinical indicators from physicians’ notes, combining that insight with traditional structured data such as lab results and vital signs. This approach enables Healthleap to deliver daily risk scores to hospital care teams, highlighting patients who may need further evaluation. Its technology currently screens for conditions including malnutrition, delirium, aspiration pneumonia, and risks of hospital readmission.
Why it matters
Many serious conditions, like malnutrition, are commonly underdiagnosed in hospital settings but have a significant impact on patient outcomes and healthcare costs. Research indicates that 20% to 50% of hospitalized patients suffer from malnutrition, which can lead to longer stays, infections, impaired recovery, and increased mortality. By identifying these risks earlier, Healthleap’s platform helps clinicians intervene sooner, improving patient care and reducing avoidable expenses.
Healthleap’s business model uses outcome-based pricing aligned with hospital financial teams, ensuring measurable return on investment. To date, all customers have realized at least a fivefold ROI, with some reporting over 20 times annual returns. For example, the Hospital of the University of Pennsylvania achieved $23.8 million in annualized financial impact tied to Healthleap’s malnutrition program.
What to watch next
With the fresh funding, Healthleap plans to bolster product development, engineering, and sales efforts to expand coverage to over 40 major health conditions. The company is also aiming to extend its platform beyond inpatient settings into outpatient and home care environments, addressing broader healthcare challenges through AI-powered risk detection.
Observing how Healthleap scales its technology across diverse hospital systems and demonstrates clinical validation for additional conditions will be key. Its continued ability to generate strong financial outcomes paired with improved clinical workflows could position it as a leader in AI-driven hospital risk management.